Works matching AU Omar, Zaayid
Results: 5
Virologic outcomes with tenofovir-lamivudinedolutegravir in adults failing PI-based second-line ART.
- Published in:
- Southern African Journal of HIV Medicine, 2024, v. 25, n. 1, p. 1, doi. 10.4102/sajhivmed.v25i1.1567
- By:
- Publication type:
- Article
INITIAL SUPPLEMENTAL DOLUTEGRAVIR DOSE IN SECOND-LINE ART: A PHASE 2 RANDOMISED TRIAL.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 206
- By:
- Publication type:
- Article
PHARMACOKINETICS OF STANDARD VS DOUBLE-DOSE DOLUTEGRAVIR AFTER SWITCH FROM EFAVIRENZ.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 199
- By:
- Publication type:
- Article
STANDARD VS DOUBLE DOSE DOLUTEGRAVIR IN HIV-ASSOCIATED TUBERCULOSIS: WEEK 48 RESULTS.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 45
- By:
- Publication type:
- Article
Initial Supplementary Dose of Dolutegravir in Second-Line Antiretroviral Therapy: A Noncomparative, Double-Blind, Randomized Placebo-Controlled Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 10, p. 1832, doi. 10.1093/cid/ciad023
- By:
- Publication type:
- Article